Most tapers do not fail because someone lacked determination. They fail at a specific, mundane point: the next dose on the plan is smaller than the smallest tablet that exists, and nobody has told the person what to do about it. This is a pharmacy problem with pharmacy solutions, and knowing they exist before you get there changes how the last stretch goes.
Where the wall is
The smallest manufactured tablet sets a floor on what you can take by breaking tablets. Alprazolam is commonly sold in a smallest strength of 0.25 mg; a taper that has come down to 0.1 mg is asking for something under half of that, reliably, every day.
Percentage-based schedules reach this point sooner than people expect — often around the halfway mark rather than at the very end. What tends to happen next is that the person holds at the lowest dose they can physically measure, stays there for months, and concludes they are stuck. They are not stuck. They have run out of tablet.
“I can’t get any lower” is almost always a supply problem wearing the costume of a personal failure.
The options, roughly in order of reliability
A manufactured oral liquid
Several of these medicines are made as oral solutions, measured with a syringe rather than counted in tablets. Where one exists for your medicine, it is usually the cleanest answer: the strength is standardised by the manufacturer, and a syringe can measure volumes far below what any tablet allows. Ask your pharmacist directly whether a licensed liquid exists for what you take — availability differs by medicine and by country, and it is not something every clinician has front of mind.
A compounding pharmacy
Compounding pharmacies prepare medicines to a specified strength, including capsules or liquids in doses no manufacturer sells. This is the usual route when no licensed liquid exists. Two practical notes: not every pharmacy compounds, so it is worth finding one before you need it, and compounded preparations are often not covered by insurance, so ask about cost early rather than at the counter.
Splitting tablets
Halving a scored tablet is reasonable. Quartering is less reliable, and going below a quarter is not something to depend on for a daily dose. Tablets are not uniformly dense, a scored line is a manufacturing convenience rather than a promise of two equal halves, and studies of split tablets have repeatedly found meaningful variation in the weight of the pieces — variation that matters more and more as the dose gets smaller and each fragment carries a larger share of what is left.
Tapering strips
In some countries pharmacies prepare pre-packaged strips of daily doses that step down gradually, each pouch labelled with its dose and day. Where available they remove the daily measuring problem entirely. Availability is limited and they are not routinely covered, so treat this as worth asking about rather than assuming.
You don’t have to figure this out alone.
The people who come off most comfortably almost always have a Provider doing it with them — someone who knows the slow way.
Find a Provider near you →What to ask for, and when
The mistake is waiting until you are already stuck. By the time you cannot make the next dose, you have often been holding for weeks and morale is low. Raising it early turns an emergency into an administrative task.
- Ask at the start, not the bottom. “When we get below tablet size, what is our plan?” is a fair question at the first appointment about tapering.
- Ask the pharmacist too. Pharmacists frequently know about a licensed liquid, or a local compounder, that the prescribing clinician does not.
- Get it in the chart. A written plan that includes the route to small doses survives a change of clinician.
- Check cost before you need it. Compounded preparations are often self-funded; knowing that in advance avoids an unpleasant surprise mid-taper.
A note on precision scales
Some people weigh fragments on a jeweller’s scale to get below tablet size. It is understandable, particularly when the alternatives have been refused, but it introduces error at exactly the point where accuracy matters most, and it puts the responsibility for dosing on the person taking the medicine. If you are considering it, that fact alone is worth raising with a clinician — it usually means the supply question has not been answered properly yet.